AFNAS
PTLA

American Financial Network Advisory Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

American Financial Network Advisory Services’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50
Closed -$3K – 796
2017
Q3 		$3K Buy
+50
New +$2.94K ﹤0.01% 677

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

American Financial Network Advisory Services's PTLA Position: Q4 2017 in Review

American Financial Network Advisory Services sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2017, closing a stake of 50 shares — an estimated $3K sold.

American Financial Network Advisory Services first reported a position in PTLA in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 215 funds tracked by Wall St. Rank hold PTLA as of Q4 2017.

  • American Financial Network Advisory Services reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2017 after selling out during the quarter.
  • American Financial Network Advisory Services sold 50 Portola Pharmaceuticals, Inc. shares in Q4 2017, an estimated $3K.
  • American Financial Network Advisory Services first reported a position in Portola Pharmaceuticals, Inc. in Q3 2017 and held it in 1 quarter.
  • American Financial Network Advisory Services's Portola Pharmaceuticals, Inc. position peaked at $3K in Q3 2017.
  • 215 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2017.

Based on American Financial Network Advisory Services's 13F filing for Q4 2017, filed 2 Jan 2018.